DublinAnd January 20 2022 /PRNewswire/ – The report “Technological enablers that facilitate the adoption of the microbiome in research and development” has been added to ResearchAndMarkets.com Show.
This research service provides an overview of the technologies that enable microbiome research. Technological enablers address challenges in microbiome data collection and analysis, product development, and manufacturing.
Academic and research institutes, public and private organizations, and companies collaborate to develop and use integrated omics, machine learning, artificial intelligence and microbial engineering tools through synthetic biology and powerful data analytics tools to manage vast amounts of microbiome data.
Knights Lab, Metabiomics, and Eagle Genomics are examples of companies that offer machine learning and data analysis tools to facilitate research into the microbiome. Pacific Biological Sciences, MacCoss Lab of the University of Washingtonand IsoPlexis are developing omics technologies to improve microbiome research and address its challenges.
The study highlights notable funding and investment trends that facilitate microbiome research globally. United State Leading the funding landscape as many public and private institutions support microbiome research and adoption, leading to increased partnerships between industry and academia.
Microbiome research is increasing in the wake of technological advances and significant reductions in the cost of microbiome analysis. Research has unlocked the potential of the microbiome in medical use cases, yielding tremendous insights into its nature, interactions, and impact within a host and in an outdoor environment.
Advanced studies on the role of microbes and their interactions with the host have enabled the development of innovative therapeutic strategies and diagnostic techniques. Research is also being conducted to explore applications of the microbiome in non-medical industries, such as agriculture, waste processing, landfills, and the marine industries.
The enabling technologies, namely digital technologies, omics, synthetic biology, and microbial farming technologies, advance microbiome research and development (R&D), manufacturing, product development, and marketing. Advances in digital technologies, such as big data analytics, machine learning, and artificial intelligence, contribute to the collection, synthesis, and analysis of microbiome data for various applications.
Omics technologies such as genomics, transcription, proteomics and metabolism are improving the characterization of microbiome data, host-microbiome interactions, microbial response to external stimuli, DNA sequencing, RNA sequencing, proteins and metabolic profiles. Synthetic biology facilitates the design of engineered microbes for therapeutics, cell-based biosensors for diagnosis, complex switches and synthetic gene networks for drug discovery.
Likewise, technological advances in high-throughput culture techniques enable the cultivation of microorganisms that were not previously culturable. These technological enablers are opening up new opportunities and applications for microbiome-based products in industries.
The study also identifies growth opportunities for companies in the microbiome value chain and covers the following key areas:
Current Microbiome Research Scenario
Challenges in microbiome research and promising solutions
Enabling Technologies for Microbiome R&D and Product Development and Commercialization
Major financing and investment deals
Growth opportunities for stakeholders in the value chain
Main topics covered:
1. Strategic imperatives
1.1 Why is it getting harder to grow? Strategic imperative 8: Factors that create pressures on growth
1.2 Strategic determinism
1.3 Impact of the three most important strategic imperatives on the technological enablers of microbiome applications
1.4 Growth opportunities fuel the growth pipeline
2. Search scope
2.1 Scope of research and key questions addressed
2.2 Research Methodology
3. Growth environment analysis
3.1 Introduction to Microbiome Technologies
3.2 The role of the microbiome in human health
3.3 The role of the microbiome across multiple disease indicators
3.4 Microbiome-based product development
3.5 Key bottlenecks in microbiome research and development and product development
3.6 The need for technology enablers in microbiome R&D and product development
4. Enabling Technology – Digital Technologies
4.1 The role of digital technologies in microbiome research and development and product development
4.2 Data analytics and machine learning tools to overcome R&D bottlenecks
4.3 Academic and research institutes develop digital tools for microbiome research
4.4 Digital innovations facilitate microbiome research
5. Empowerment Technology – Omics Platforms
5.1 Omics’ role in microbiome R&D and product development
5.2 Omics Technologies Facilitates Microbiome Research
5.3 Academic and Research Institutes Advanced Omics Platforms for Microbiome Analysis
5.4 Key stakeholders develop Omics platforms for research and development in the microbiome
5.5 Companies are eager to use Omics platforms to develop products
6. Enabling Technology – Synthetic Biology
6.1 The role of synthetic biology in microbiome research and development and product development
6.2 Synthetic biology has increasing applications in microbiome therapies and diagnosis
6.3 Academic and research institutes focus on microbial engineering
6.4 Research institutes explore the potential of the microbiome in non-medical applications
6.5 Synthetic biology innovations enable microbial engineering
7. Enabling Technology – Agriculture Techniques
7.1 The role of culture techniques in microbiome research and development and product development
7.2 Innovations in farming techniques reduce R&D lead time
7.3 Academic institutes improve microbial culture techniques
7.4 Innovations in the culture of uncultivable microbes
8. Financing and investment analysis
8.1 Increase research investment and grants for microbiome research
8.2 Federal Funding Supports Microbiome Research
8.3 Ongoing trends in microbiome investments
8.4 Mergers, acquisitions and collaborations aim to increase the commercialization of microbiome-based products
9. The universe’s growth opportunities
9.1 Growth opportunity 1: Develop advanced data analysis tools for effective microbiome research and development and product development
9.2 Growth Opportunity 2: Standardize and Create Reference Materials to Advance Microbiome Research
9.3 Growth Opportunity 3: Synthetic Biology Techniques to Accelerate Large-Scale Production of Engineered Strains
10. Next steps
For more information on this report, visit https://www.researchandmarkets.com/r/hhnmu3
Research and Markets
Laura Wood, director, mentor
For EST office hours, call +1-917-300-0470
For the US/Canada, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900
US Fax: 607-646-1907
Fax (outside the US): +353-1-481-1716
View original content: https://www.prnewswire.com/news-releases/global-microbiome-adoption-market-research-report-2021-advancements-in-analytical-methods-and-digital-tools-fuel-growth- Opportunities in Research and Product Development in the Microbiome 301465174.html
SOURCE Research & Markets